MML Investors Services
UTHR icon

MML Investors Services’s United Therapeutics UTHR Stock Holding History

MML Investors Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
3,515
+563
+19% +$317K ﹤0.01% 1568
2026
Q1 		$1.75M Sell
2,952
-362
-11% -$180K ﹤0.01% 1397
2025
Q4 		$1.61M Buy
3,314
+1,040
+46% +$484K ﹤0.01% 1499
2025
Q3 		$953K Sell
2,274
-499
-18% -$168K ﹤0.01% 1761
2025
Q2 		$797K Buy
2,773
+466
+20% +$139K ﹤0.01% 1791
2025
Q1 		$711K Sell
2,307
-747
-24% -$256K ﹤0.01% 1787
2024
Q4 		$1.08M Buy
3,054
+2,370
+346% +$871K ﹤0.01% 1449
2024
Q3 		$245K Buy
+684
New +$231K ﹤0.01% 2312
2024
Q1 		– Sell
-2,099
Closed -$461K – 2568
2023
Q4 		$461K Buy
+2,099
New +$484K ﹤0.01% 1801
2022
Q1 		– Sell
-2,100
Closed -$454K – 2145
2021
Q4 		$454K Buy
2,100
+38
+2% +$7.46K ﹤0.01% 1472
2021
Q3 		$381K Buy
2,062
+359
+21% +$70.7K ﹤0.01% 1509
2021
Q2 		$306K Buy
+1,703
New +$324K ﹤0.01% 1604

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

MML Investors Services's UTHR Position: Q2 2026 in Review

MML Investors Services increased its United Therapeutics (UTHR) stake by 19% in Q2 2026, buying an estimated $317K and bringing the position to 3,515 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1568.

MML Investors Services first reported a position in UTHR in Q2 2021 and has held it in 12 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • MML Investors Services held 3,515 shares of United Therapeutics worth $1.9M as of Q2 2026.
  • MML Investors Services bought 563 United Therapeutics shares in Q2 2026, an estimated $317K.
  • United Therapeutics made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #1568 holding.
  • MML Investors Services first reported a position in United Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.